The popular DOAC was linked to more bleeding events than warfarin, but fewer reports of intracardiac thrombi and other adverse outcomes. Researchers presented their findings at the AHA's Scientific Sessions 2024 conference in Chicago.

Vessel harvesting devices from Getinge have been recalled due to pieces breaking off during medical procedures. In some cases, surgeons were unable to retrieve the broken pieces. 

J.D. Corl, MD, shared his experience using two new IVL catheters from Shockwave Medical to treat patients with heavily calcified peripheral arteries. He considers both new devices a significant upgrade. 

Treating patients younger than 65 with TAVR is associated with certain risks for heart teams to consider. Fortunately, researchers found, care teams appear to be choosing patients wisely. 

The Sensora platform, which includes multiple FDA-approved algorithms, has a new Category III CPT code.

Demand for inpatient and outpatient cardiology services is expected to increase significantly in the next decade, putting hospitals and health systems in a position where they need to plan ahead or risk falling behind. 

The popular diabetes drug, which can also benefit patients with heart failure and sleep apnea, resulted in an average weight loss of 23%. Once treatment stopped, the effects started to fade rather quickly. 

The new technology, still under development, could help physicians screen patients for diabetes and hypertension with high-speed video recordings.